Episode Details

Three months later… and still no update.In today’s episode of TDR Cannabis in 5, presented by Flowhub, we break down the growing pressure on the Department of Justice as delays continue around federal cannabis rescheduling.Back on December 18th, President Donald Trump signed an executive order directing the DOJ to move cannabis from Schedule I to Schedule III. At the time, markets reacted quickly — with expectations that this would move fast.But here we are now… and nothing has changed.According to new reporting from Marijuana Moment, Congressman Steve Cohen is now demanding answers from Attorney General Pam Bondi and the DEA, asking a simple question: where is the timeline?This isn’t just about politics — it’s about execution.Because while the executive order created momentum, the actual rescheduling process still requires a formal rulemaking process. And right now, that process appears stalled.We also get into a key issue that’s flying under the radar — the DOJ missing a federal deadline tied to cannabis research reform, which only adds more pressure to an already delayed process.For investors, this matters.The market priced in speed… and now it’s dealing with uncertainty.Until a final rule is published, cannabis remains a Schedule I substance — and that means no real change yet.00:04:50 — Key Takeaways Ahead#CannabisIndustry #CannabisRescheduling #DOJ #DEA #CannabisStocks #CannabisNews #FederalReform #Schedule3 #TDR #CannabisInvestingWant to see more Cannabis Reform videos?🎬    • CLIMB Act Could Change Cannabis Forever | ...  🎬    • Medicare CBD Program Raises Questions In W...  🎬    • Does Cannabis Rescheduling Actually Unlock...  🎬    • Texas Hemp Ban Creates Winners And Losers ...  Want to stay updated on Cannabis, Small Cap, AI, and Crypto?Subscribe to our Daily Baked newsletter:https://newsletter.thedalesreport.com...Find us on social media and podcast platforms:✅ Facebook:   / thedalesreport  ✅ Twitter:   / thedalesrepo